4-Piperazinyl benzenesulfonamide is a chemical compound characterized by its piperazine moiety and a sulfonamide functional group attached to a benzene ring. This compound typically exhibits properties associated with sulfonamides, such as antibacterial activity, due to the presence of the sulfonamide group, which can inhibit bacterial growth by interfering with folic acid synthesis. The piperazine ring contributes to its pharmacological properties, often enhancing solubility and bioavailability. In terms of physical properties, it is generally a solid at room temperature, with potential for moderate to high melting points, depending on its specific crystalline form. The compound may also exhibit polar characteristics due to the sulfonamide group, influencing its interactions in biological systems. Its applications may extend to medicinal chemistry, particularly in the development of therapeutic agents targeting various diseases. As with many sulfonamides, it is essential to consider potential side effects and interactions when evaluating its use in clinical settings.

4-PIPERAZINYL BENZENESULFONAMIDE

121278-31-7: 4-Piperazinyl benzenesulfonamide is a chemical compound characterized by its piperazine moiety and a sulfonamide functional group attached to a benzene ring. This compound typically exhibits properties associated with sulfonamides, such as antibacterial activity, due to the presence of the sulfonamide group, which can inhibit bacterial growth by interfering with folic acid synthesis. The piperazine ring contributes to its pharmacological properties, often enhancing solubility and bioavailability. In terms of physical properties, it is generally a solid at room temperature, with potential for moderate to high melting points, depending on its specific crystalline form. The compound may also exhibit polar characteristics due to the sulfonamide group, influencing its interactions in biological systems. Its applications may extend to medicinal chemistry, particularly in the development of therapeutic agents targeting various diseases. As with many sulfonamides, it is essential to consider potential side effects and interactions when evaluating its use in clinical settings.

CAS 121278-31-7

4-PIPERAZINYL BENZENESULFONAMIDE